Dimensional Fund Advisors LP boosted its holdings in Cronos Group Inc. (NASDAQ:CRON - Free Report) by 5.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,753,055 shares of the company's stock after acquiring an additional 132,536 shares during the period. Dimensional Fund Advisors LP owned about 0.72% of Cronos Group worth $5,561,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Thompson Davis & CO. Inc. acquired a new position in shares of Cronos Group during the fourth quarter valued at approximately $29,000. SBI Securities Co. Ltd. acquired a new stake in shares of Cronos Group during the 4th quarter valued at $30,000. Jones Financial Companies Lllp boosted its stake in shares of Cronos Group by 64.5% during the 4th quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock valued at $34,000 after buying an additional 6,520 shares during the period. Zacks Investment Management bought a new stake in Cronos Group in the fourth quarter worth $38,000. Finally, Headlands Technologies LLC increased its holdings in shares of Cronos Group by 904.4% during the 4th quarter. Headlands Technologies LLC now owns 28,917 shares of the company's stock valued at $58,000 after acquiring an additional 26,038 shares during the last quarter. Institutional investors own 8.71% of the company's stock.
Cronos Group Stock Up 2.9%
CRON stock traded up $0.06 during mid-day trading on Friday, reaching $2.14. 2,692,520 shares of the stock traded hands, compared to its average volume of 1,293,265. Cronos Group Inc. has a 52 week low of $1.60 and a 52 week high of $2.90. The business has a 50-day moving average of $1.83 and a two-hundred day moving average of $1.94. The firm has a market capitalization of $824.77 million, a PE ratio of -16.46, a P/E/G ratio of 1.74 and a beta of 1.06.
Cronos Group (NASDAQ:CRON - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.02 earnings per share for the quarter, beating analysts' consensus estimates of $0.01 by $0.01. The business had revenue of $33.62 million for the quarter, compared to analysts' expectations of $45.44 million. Cronos Group had a negative net margin of 42.65% and a negative return on equity of 2.56%. On average, equities research analysts anticipate that Cronos Group Inc. will post -0.03 EPS for the current fiscal year.
About Cronos Group
(
Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
